A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.

Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...

The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment ...

The measurement of serum CA-125 antigen is a standard procedure in the management of patients with advanced ovarian cancer. A study by Markman et al. showed that decreased concentration of serum ...

A recent retrospective analysis by Low and colleagues compared the use of laparotomy, MRI, and serum cancer antigen-125 (CA-125) levels for the detection of residual tumor in women treated for ...

PID is characterized by an endometritis-salpingitis-peritonitis complex. Acute salpingitis occurs in 20% to 50% of patients with PID and affects 2 in every 100 young women between the ages of 15 ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood, and ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...